News Releases

NIH Funds New Center to Treat Chronic Pain and Opioid Use Disorder at Einstein and Montefiore
Einstein and Montefiore Researchers Awarded $7.6 Million in NIH Grants to Study Depression in People Living with HIV
Einstein Early-Career Scientists Secure K Grants

Facts & Stats

Published Papers
NIH Research Funding
Students
Full-time Faculty
Global Initiatives
Clinical and Research Centers
Alumni

Expert List for Media

Elizabeth A. Walker

Elizabeth A. Walker, Ph.D.

Area(s) of expertise: Diabetes Self-Management (behavior change)Type 2 diabetesBehavioral intervention

Dr. Walker is a nurse scientist, diabetes nurse specialist and certified diabetes educator who specializes in studying how to help people with diabetes better manage their disease by adhering to their medication regimen,… Learn more

Einstein in the News


KNX In Depth
Omicron Arrives On the Scene

Kartik Chandran, Ph.D., says there is much to learn about the new COVID-19 variant, omicron, including if it is more likely to cause severe disease or spread more easily that currently dominant variants. He notes the importance of vaccination and getting booster shots to protect against the virus. Dr. Chandran is professor of microbiology & immunology and the Harold and Muriel Block Scholar in Virology at Einstein. (Interview begins at 1:22)

More coverage on Dr. Chandran

CBS News
Searching for a Fountain of Youth

Nir Barzilai, M.D., talks about his plans for a clinical trial to study metformin, a diabetes drug, to target age-related diseases and to extend both lifespan and health span. Dr. Barzilai is professor of medicine and of genetics, the Ingeborg and Ira Leon Rennert Chair in Aging Research and director of the Institute for Aging Research at Einstein, and an endocrinologist at Montefiore. (Interview begins at 2:45)

More coverage on Dr. Barzilai

Medscape
Booster May Up Antibodies in Patients With Cancer When Standard Dose Fails

Lauren Shapiro, M.D., and Astha Thakkar, M.B.B.S., discuss their study that found that most cancer patients who had no measurable immune response after being fully vaccinated for COVID-19 developed antibodies following a booster shot. Drs. Shapiro and Thakkar are third-year hematology/oncology fellows at Albert Einstein College of Medicine and Montefiore Medical Center.

Additional Coverage includes UPI, U.S. News & World Report (via HealthDay), MedPage Today

Multimedia

When a Drug Becomes a Child’s Last Hope

Einstein scientist Vern Schramm, Ph.D., never imagined that his basic research into enzymes would intersect with a 2-year-old girl dying from an incurable form of blood cancer. He and that girl (Katie Lambertson, now a teenager) and her parents share their stories.

Watch more videos

The Doctor's Tablet Blog